AP2038A
(en )
2009-09-04
Treatment of aqueous suspensions
PL1615966T5
(en )
2020-06-29
Aqueous dispersions and coatings
IL221199A0
(en )
2012-09-24
Pharmaceutical identification
IL166171A0
(en )
2006-01-15
Blood clot-targeted nanoparticles
PL378135A1
(en )
2006-03-06
2-cyanopyrrolopyrimidines and pharmaceutical uses thereof
FI7846U1
(en )
2008-04-28
Pharmaceutical preparation containing oxycodone and naloxone
EP1591058A4
(en )
2013-01-23
Medical device-guiding system
GB0303797D0
(en )
2003-03-26
Blood assessment
PL359321A1
(en )
2003-10-20
New salt perindopryl and pharmaceutical composunds containing it
AU158445S
(en )
2005-12-06
Pharmaceutical packaging
EP1519734A4
(en )
2011-02-23
Ciclesonide-containing sterile aqueous suspension
GB0316889D0
(en )
2003-08-20
Pharmaceutical agents
GB0411165D0
(en )
2004-06-23
Hyaluronic acid containing pharmaceutical or veterinary compounds
EP1541174A4
(en )
2005-09-14
Drug or cosmetic
EP1634499A4
(en )
2010-11-24
Aqueous compositions for disinfection and/or sterilization
HUP0201700A3
(en )
2003-02-28
Stable xylometazoline and oxymetazoline solutions, their use for producing pharmaceutical compositions and pharmaceutical compositions containing them
SI1634589T1
(en )
2011-05-31
Aqueous olanexidine solution, method of preparing the same, and disinfectant
SI1663141T1
(en )
2007-10-31
Aqueous pharmaceutical solution containing oxymetazoline and/or xylometazoline
GB2401043B
(en )
2007-10-17
Drug
GB0316910D0
(en )
2003-08-20
Fluorocombretastatin and derivatives thereof
EP1634590A4
(en )
2009-04-08
Coronavirus inactivating agent
PL355453A1
(en )
2004-02-23
Pharmaceutical agent
GB0515003D0
(en )
2005-08-31
Medical devices and coatings therefor
PL1653963T3
(en )
2007-02-28
Nasal pharmaceutical piribedil composition
GB0307654D0
(en )
2003-05-07
Oesophageal catheter